Existing-plan tracker · GLP-1

Keep your semaglutide routine together.

Semaglutide is a GLP-1 receptor agonist. The current Wegovy prescribing information reports the timing shown below for that product; your prescribed product and plan may differ.

Listed injectable brands include Ozempic® and Wegovy®. Sculpi is not affiliated with their manufacturers.

Reported half-life

About 1 week

Reported Tmax

1–3 days

Label schedule

Once weekly for the listed injectables

These population-level facts do not measure your concentration, predict benefit or side effects, explain a symptom, or set your schedule. Read the complete FDA Wegovy prescribing information (2026) and follow your own prescription.

A record of the plan you already have.

Sculpi keeps your entered plan, dose history, symptoms and supportive routines together. It does not select a medication, dose, schedule or injection site.

✓Reminders you choose, with quiet hours
✓A history of the injection sites you record
✓User-defined protein, fiber and water targets
✓At-home and gym movement logs

Private by design

Your health record is not a marketing profile.

On iOS, app records are stored locally and can sync through the user's private iCloud database. Android records stay local in the current release. Optional connected services remain off until you choose them.

Read the privacy details

Bring a clearer history to your next conversation.

Check app availability

Educational companion only—not medical advice, diagnosis or treatment. Follow your product label and licensed clinician or pharmacist.